Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.8.3533

Health-related Quality of Life in Women with Breast Cancer: a Literature-based Review of Psychometric Properties of Breast Cancer-specific Measures  

Niu, Hui-Yan (Department of Geriatrics, Shengjing Hospital, China Medical University)
Niu, Chun-Ying (School of Public Health, University of Alberta)
Wang, Jia-He (Department of Geriatrics, Shengjing Hospital, China Medical University)
Zhang, Yi (Department of Geriatrics, Shengjing Hospital, China Medical University)
He, Ping (Department of Geriatrics, Shengjing Hospital, China Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.8, 2014 , pp. 3533-3536 More about this Journal
Abstract
Background: Breast cancer is one of the most common cancers in women in the world. Health-related quality of life (HRQL) at treatment endpoint in cancer clinical trials is widely considered to be increasingly important. The aim of this review was to provide a literature-based assessment of the validity, reliability and responsiveness of breast cancer-specific HRQL instruments in women breast cancer patients. Materials and Methods: The databases consulted were Medline, PubMed, and Embase. The inclusion criteria required studies to: (1) involve use of HRQL measures; (2) cover women with breast cancer under standard treatment (surgery, radiation therapy, chemotherapy, hormone therapy, and targeted therapy); (3) involve the validity, reliability, or responsiveness of HRQL; (4) deal with validation of breast cancer-specific HRQL instruments. Results: A total of 16 studies were identified through the literature search that met the 4 inclusion criteria. Some seven instruments were assessed among these 16 studies: EORTC QLQ-BR23, FACT-B, FACT-ES, HFRDIS, LSQ-32, QLICP-BR, and SLDS-BC. EORTC QLQ-BR23, FACT-B, LSQ-32, QLICP-BR, and SLDS-BC are more general breast cancer-specific HRQL instruments. FACT-EB is the endocrine subscale combined with FACT-B in order to measure the side effects and putative benefits of hormonal treatment administered in breast cancer patients. HFRDIS is the HRQL measure focusing on hot flash concerns. Conclusions: This paper provides an overall understanding on the currently available breast cancer-specific HRQL instruments in women breast cancer patients.
Keywords
Breast cancer; health-related quality of life; instrument; validity; reliability;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Carpenter JS, Andrykowski MA, Cordova M, et al (1998). Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer, 82, 1682-91.   DOI
2 Wan C, Tang X, Tu XM, et al (2007a). Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients. Breast Cancer Res Treat, 105, 187-93.   DOI   ScienceOn
3 Terwee CB, Bot SD, de Boer MR, et al (2007). Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol, 60, 34-42.   DOI   ScienceOn
4 Wan C, Yang Z, Tang X, et al (2009). Development and validation of the system of quality of life instruments for cancer patients: breast cancer (QLICP-BR). Support Care Cancer, 17, 359-66.   DOI
5 Wan C, Zhang D, Yang Z, et al (2007b). Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat, 106, 413-8.   DOI
6 Whelan TJ, Goss PE, Ingle JN, et al (2005). Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol, 23, 6931-40.   DOI   ScienceOn
7 Whelan TJ, Pritchard KI (2006). Managing patients on endocrine therapy: focus on quality-of-life issues. Clin Cancer Res, 12, 1056-60.   DOI   ScienceOn
8 Yun YH, Bae SH, Kang IO, et al (2004). Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) Breast-Cancer-Specific Quality of Life Questionnaire (EORTC QLQ-BR23). Support Care Cancer, 12, 441-5.   DOI   ScienceOn
9 Montazeri A, Harirchi I, Vahdani M, et al (2000). The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Qual Life Res, 9, 177-84.   DOI   ScienceOn
10 Mohammadi S, Sulaiman S, Koon PB, et al (2013). Association of nutritional status with quality of life in breast cancer survivors. Asian Pac J Cancer Prev, 14, 7749-55.   과학기술학회마을   DOI   ScienceOn
11 Montazeri A (2008). Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res, 27, 32.   DOI   ScienceOn
12 Montazeri A, Gillis CR, McEwen J (1996). Measuring quality of life in oncology: is it worthwhile? I. Meaning, purposes and controversies. Eur J Cancer Care (Engl), 5, 159-67.   DOI   ScienceOn
13 Munoz M (2010). Quality of life during treatment in young women with breast cancer. Breast Cancer Res Treat, 123, 75-7.   DOI
14 Ng R, Lee CF, Wong NS, et al (2012). Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Asian breast cancer patients. Breast Cancer Res Treat, 131, 619-25.   DOI   ScienceOn
15 Sprangers MA, Groenvold M, Arraras JI, et al (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14, 2756-68.
16 Pandey M, Thomas BC, Ramdas K, et al (2002). Quality of life in breast cancer patients: validation of a FACT-B Malayalam version. Qual Life Res, 11, 87-90.   DOI   ScienceOn
17 Scholtes VA, Terwee CB, Poolman RW (2011). What makes a measurement instrument valid and reliable? Injury, 42, 236-40.   DOI   ScienceOn
18 Spagnola S, Zabora J, BrintzenhofeSzoc K, et al (2003). The Satisfaction with Life Domains Scale for Breast Cancer (SLDS-BC). Breast J, 9, 463-71.   DOI   ScienceOn
19 Fallowfield LJ, Leaity SK, Howell A, et al (1999). Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat, 55, 189-99.
20 Cerezo O, Onate-Ocana LF, Arrieta-Joffe P, et al (2012). Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer. Eur J Cancer Care (Engl), 21, 684-91.   DOI   ScienceOn
21 Chie WC, Chang KJ, Huang CS, et al (2003). Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23. Psychooncology, 12, 729-35.   DOI   ScienceOn
22 Couzi RJ, Helzlsouer KJ, Fetting JH (1995). Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol, 13, 2737-44.
23 Lemieux J, Goodwin PJ, Bordeleau LJ, et al (2011). Qualityof-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009). J Natl Cancer Inst, 103, 178-231.   DOI   ScienceOn
24 Ganz PA, Desmond KA, Leedham B, et al (2002). Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst, 94, 39-49.   DOI   ScienceOn
25 Goodwin PJ, Black JT, Bordeleau LJ, et al (2003). Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock. J Natl Cancer Inst, 95, 263-81.   DOI   ScienceOn
26 Jayasekara H, Rajapaksa LC, Brandberg Y (2008). Measuring breast cancer-specific health-related quality of life in South Asia: psychometric properties of the Sinhala version of the EORTC QLQ-BR23. Qual Life Res, 17, 927-32.   DOI
27 Ahmad Kiadaliri A, Bastani P, Ibrahimipour H (2012). Healthrelated quality of life of breast cancer patients in Iran: pooled analysis using generalized estimating equations. Asian Pac J Cancer Prev, 13, 941-4.   DOI   ScienceOn
28 Brady MJ, Cella DF, Mo F, et al (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol, 15, 974-86.
29 Carlsson M, Hamrin E (1996). Measurement of quality of life in women with breast cancer. Development of a Life Satisfaction Questionnaire (LSQ-32) and a comparison with the EORTC QLQ-C30. Qual Life Res, 5, 265-74.   DOI
30 Carpenter JS (2001). The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage, 22, 979-89.   DOI   ScienceOn